Horiba ABX, which develops automated in vitro diagnostics systems for haematology and clinical chemistry applications, has changed its name to Horiba Medical.
Horiba's innovations in in-vitro diagnostics include the ABX Pentra 60C+, which uses flow cytometry and cytochemistry to count leucocytes.
Horiba Medical invests more than 10 per cent of its turnover into research and development.
Horiba Medical's products range from compact point-of-care (POC) analysers to high-throughput systems.
